{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:02:32Z","timestamp":1791151352862,"version":"4.1.0"},"reference-count":217,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.pharmthera.2012.07.012","type":"journal-article","created":{"date-parts":[[2012,7,29]],"date-time":"2012-07-29T17:31:06Z","timestamp":1343583066000},"page":"267-282","source":"Crossref","is-referenced-by-count":56,"title":["Dipeptidyl peptidase 4 as a therapeutic target in ischemia\/reperfusion injury"],"prefix":"10.1016","volume":"136","author":[{"given":"Veerle","family":"Matheeussen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Jungraithmayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"De Meester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2012.07.012_bb0005","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1161\/01.CIR.0000147780.30124.CF","article-title":"Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury","volume":"110","author":"Abbott","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0010","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1152\/jappl.1992.72.2.492","article-title":"Compounds that increase cAMP prevent ischemia\u2013reperfusion pulmonary capillary injury","volume":"72","author":"Adkins","year":"1992","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0015","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1097\/00007890-199505150-00005","article-title":"Enhancement of extended lung preservation with a vasoactive intestinal peptide-enriched University of Wisconsin solution","volume":"59","author":"Alessandrini","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0020","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/00007890-199310000-00036","article-title":"Vasoactive intestinal peptide enhances lung preservation","volume":"56","author":"Alessandrini","year":"1993","journal-title":"Transplantation"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0025","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1515\/CCLM.2009.063","article-title":"Recent insights into the role of dipeptidyl aminopeptidase IV (DPIV) and aminopeptidase N (APN) families in immune functions","volume":"47","author":"Ansorge","year":"2009","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0030","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.healun.2009.03.015","article-title":"Post-ischemic infusion of atrial natriuretic peptide attenuates warm ischemia\u2013reperfusion injury in rat lung","volume":"28","author":"Aoyama","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0035","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0140-6736(03)14232-8","article-title":"Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy","volume":"362","author":"Askari","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0040","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1210\/en.2009-1197","article-title":"Glucagon-like peptide (GLP)-1(9\u201336)amide-mediated cytoprotection is blocked by exendin(9\u201339) yet does not require the known GLP-1 receptor","volume":"151","author":"Ban","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0045","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1161\/CIRCULATIONAHA.107.739938","article-title":"Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways","volume":"117","author":"Ban","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0050","doi-asserted-by":"crossref","first-page":"e23570","DOI":"10.1371\/journal.pone.0023570","article-title":"Albiglutide, a long lasting glucagon-like peptide-1 analog, protects the rat heart against ischemia\/reperfusion injury: evidence for improving cardiac metabolic efficiency","volume":"6","author":"Bao","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0055","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1002\/jcb.23261","article-title":"Neuroimmunomodulative properties of dipeptidyl peptidase IV\/CD26 in a TNBS-induced model of colitis in mice","volume":"112","author":"Baticic","year":"2011","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0060","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s00395-004-0458-7","article-title":"Natriuretic peptides and myocardial ischaemia","volume":"99","author":"Baxter","year":"2004","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0065","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/304368a0","article-title":"Exon duplication and divergence in the human preproglucagon gene","volume":"304","author":"Bell","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0070","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/302716a0","article-title":"Hamster preproglucagon contains the sequence of glucagon and two related peptides","volume":"302","author":"Bell","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1213\/01.ANE.0000093249.35075.F1","article-title":"A-type and B-type natriuretic peptides in cardiac surgical procedures","volume":"98","author":"Berendes","year":"2004","journal-title":"Anesth Analg"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0080","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.clinthera.2006.01.015","article-title":"Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers","volume":"28","author":"Bergman","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0085","first-page":"L151","article-title":"Vasoactive intestinal peptide prevents lung injury due to xanthine\/xanthine oxidase","volume":"259","author":"Berisha","year":"1990","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0090","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/sj.embor.7400598","article-title":"The hypoxia-inducible-factor hydroxylases bring fresh air into hypoxia signalling","volume":"7","author":"Berra","year":"2006","journal-title":"EMBO Rep"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0095","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2337\/diabetes.54.1.146","article-title":"Glucagon-like peptide 1 can directly protect the heart against ischemia\/reperfusion injury","volume":"54","author":"Bose","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10557-005-6892-4","article-title":"Glucagon like peptide-1 is protective against myocardial ischemia\/reperfusion injury when given either as a preconditioning mimetic or at reperfusion in an isolated rat heart model","volume":"19","author":"Bose","year":"2005","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0105","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10557-007-6030-6","article-title":"Myocardial ischaemia-reperfusion injury is attenuated by intact glucagon like peptide-1 (GLP-1) in the in vitro rat heart and may involve the p70s6K pathway","volume":"21","author":"Bose","year":"2007","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0110","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1373\/clinchem.2005.057638","article-title":"Dipeptidyl-peptidase IV converts intact B-type natriuretic peptide into its des-SerPro form","volume":"52","author":"Brandt","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/0-387-32824-6_1","article-title":"Peptide substrates of dipeptidyl peptidases","volume":"575","author":"Brandt","year":"2006","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1392.013","article-title":"AMD3100 and CD26 modulate mobilization, engraftment, and survival of hematopoietic stem and progenitor cells mediated by the SDF-1\/CXCL12-CXCR4 axis","volume":"1106","author":"Broxmeyer","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0125","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1210\/en.137.7.2968","article-title":"Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor","volume":"137","author":"Bullock","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0130","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00395-007-0672-1","article-title":"B-type natriuretic peptide at early reperfusion limits infarct size in the rat isolated heart","volume":"102","author":"Burley","year":"2007","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0135","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/sj.bjp.0707409","article-title":"Cardioprotective actions of peptide hormones in myocardial ischemia","volume":"12","author":"Burley","year":"2007","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0140","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s10741-007-9029-y","article-title":"Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signaling","volume":"152","author":"Burley","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0145","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1084\/jem.20052144","article-title":"A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development","volume":"203","author":"Burns","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0150","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1161\/CIRCULATIONAHA.106.179294","article-title":"Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association","volume":"115","author":"Buse","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0155","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1089\/scd.2007.9995","article-title":"Inhibition of CD26 in human cord blood CD34+ cells enhances their engraftment of nonobese diabetic\/severe combined immunodeficiency mice","volume":"16","author":"Campbell","year":"2007","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0160","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.tcm.2005.02.002","article-title":"Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue","volume":"15","author":"Ceradini","year":"2005","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0165","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/nm1075","article-title":"Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1","volume":"10","author":"Ceradini","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2012.01.011","article-title":"Cardioprotective effect of dipeptidyl peptidase-4 inhibitor during ischemia\u2013reperfusion injury","author":"Chinda","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0175","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1164\/rccm.200409-1243OC","article-title":"The effect of primary graft dysfunction on survival after lung transplantation","volume":"171","author":"Christie","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0180","doi-asserted-by":"crossref","first-page":"7000","DOI":"10.4049\/jimmunol.169.12.7000","article-title":"Cell surface peptidase CD26\/dipeptidylpeptidase IV regulates CXCL12\/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells","volume":"169","author":"Christopherson","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0185","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1126\/science.1097071","article-title":"Modulation of hematopoietic stem cell homing and engraftment by CD26","volume":"305","author":"Christopherson","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0190","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1620\/tjem.215.257","article-title":"Atrial natriuretic peptide attenuates ischemia\/reperfusion-induced renal injury by reducing neutrophil activation in rats","volume":"215","author":"Chujo","year":"2008","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0195","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.clinthera.2008.03.004","article-title":"Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor alogliptino: a randomized, double-mind, placebo-controlled, multiple-dose study in adult patients with type 2 diabetes","volume":"30","author":"Covington","year":"2008","journal-title":"Clin Ther"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0200","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1158\/0008-5472.CAN-07-1589","article-title":"Hypoxia-inducible factor-1 target genes as indicators of tumor vessel response to vascular endothelial growth factor inhibition","volume":"68","author":"Dang","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0205","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1749-6632.1998.tb11190.x","article-title":"Coordinated role of vasoactive intestinal peptide and nitric oxide in cardioprotection","volume":"865","author":"Das","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0210","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1182\/blood-2003-12-4423","article-title":"SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells","volume":"104","author":"De Falco","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0215","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0960-5428(96)00002-2","article-title":"VIP modulation of immune cell functions","volume":"6","author":"De la Fuente","year":"1996","journal-title":"Adv Neuroimmunol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0220","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1463-1326.2010.01306.x","article-title":"Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review","volume":"13","author":"Deacon","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0225","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1749-6632.1999.tb07909.x","article-title":"VIP and PACAP38 modulate cytokine and nitric oxide production in peritoneal macrophages and macrophage cell lines","volume":"897","author":"Delgado","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0230","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1055\/s-0031-1271777","article-title":"Glucagon-like peptide-1 (GLP-1), immediately prior to reperfusion, decreases neutrophil activation and reduces myocardial infarct size in rodents","volume":"43","author":"Dokken","year":"2011","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0235","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/gut.19.11.1049","article-title":"Vasoactive intestinal peptide in man: pharmacokinetics, metabolic and circulatory effects","volume":"19","author":"Domschke","year":"1978","journal-title":"Gut"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0240","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1053\/gast.2002.31068","article-title":"Biological actions and therapeutic potential of the glucagon-like peptides","volume":"122","author":"Drucker","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0245","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2006.01.004","article-title":"The biology of incretin hormones","volume":"3","author":"Drucker","year":"2006","journal-title":"Cell Metab"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0250","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","article-title":"The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes","volume":"368","author":"Drucker","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0255","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.pharmthera.2003.11.001","article-title":"Autocrine and paracrine actions of natriuretic peptides in the heart","volume":"101","author":"D'Souza","year":"2004","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0260","first-page":"U11","article-title":"Cardioprotective action of type-B natriuretic peptide is NO-dependent","volume":"138","author":"D'Souza","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0265","doi-asserted-by":"crossref","first-page":"H1592","DOI":"10.1152\/ajpheart.00902.2002","article-title":"B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening","volume":"284","author":"D'Souza","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0270","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/CIRCULATIONAHA.107.758516","article-title":"Hypoxia-inducible factor-1 is central to cardioprotection: a new paradigm for ischemic preconditioning","volume":"118","author":"Eckle","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0275","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.yjmcc.2007.02.001","article-title":"Ex vivo delivered stromal cell-derived factor-1alpha promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium","volume":"42","author":"Elmadbouh","year":"2007","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0280","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/nm.2507","article-title":"Ischemia and reperfusion\u2014from mechanism to translation","volume":"17","author":"Eltzschig","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0285","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1182\/blood-2006-02-001016","article-title":"Endothelial catabolism of extracellular adenosine during hypoxia: the role of surface adenosine deaminase and CD26","volume":"108","author":"Eltzschig","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0290","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.2337\/dc10-0187","article-title":"The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha","volume":"33","author":"Fadini","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0295","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3810\/pgm.2010.05.2138","article-title":"A systematic assessment of cardiovascular outcomes in the saxagliptin drug development program for type 2 diabetes","volume":"122","author":"Frederich","year":"2010","journal-title":"Postgrad Med"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0300","doi-asserted-by":"crossref","first-page":"F414","DOI":"10.1152\/ajprenal.00174.2007","article-title":"Dipeptidyl peptidase IV inhibition downregulates Na+\u2013H+ exchanger NHE3 in rat renal proximal tubule","volume":"294","author":"Girardi","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0305","doi-asserted-by":"crossref","first-page":"C1238","DOI":"10.1152\/ajpcell.00186.2004","article-title":"Role of dipeptidyl peptidase IV in regulating activity of Na+\/H+ exchanger isoform NHE3 in proximal tubule cells","volume":"287","author":"Girardi","year":"2004","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0310","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.00075.2012","article-title":"DPP4 inhibition improves functional outcome after renal ischemia reperfusion injury","author":"Glorie","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0315","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0167-0115(01)00300-7","article-title":"Vasorelaxant effect of glucagon-like peptide-(7\u201336)amide and amylin on the pulmonary circulation of the rat","volume":"102","author":"Golpon","year":"2001","journal-title":"Regul Pept"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0320","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/eurjhf\/hfr146","article-title":"Dipeptidyl peptidase IV inhibition improves cardiorenal function in overpacing-induced heart failure","volume":"14","author":"Gomez","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0325","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00395-010-0097-0","article-title":"Role of cGMP-PKG signaling in the protection of neonatal rat cardiac myocytes subjected to simulated ischemia\/reoxygenation","volume":"105","author":"Gorbe","year":"2010","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0330","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev.ph.57.030195.001523","article-title":"Physiologic mechanisms of postischemic tissue injury","volume":"57","author":"Granger","year":"1995","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0335","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/j.1476-5381.2009.00376.x","article-title":"Emerging cardiovascular actions of the incretin hormone glucagon-like peptide-1: potential therapeutic benefits beyond glycaemic control?","volume":"157","author":"Grieve","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0340","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejphar.2005.12.055","article-title":"Novel concepts of neuropeptide-based drug therapy: vasoactive intestinal polypeptide and its receptors","volume":"533","author":"Groneberg","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0345","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00019501-199706000-00002","article-title":"Myocardial and gastrointestinal release of vasoactive intestinal peptide during experimental acute myocardial infarction","volume":"8","author":"Gyongyosi","year":"1997","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0350","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0167-5273(96)02737-4","article-title":"Elevated levels of plasma vasoactive intestinal peptide in human acute myocardial infarction","volume":"56","author":"Gyongyosi","year":"1996","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0355","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00395-010-0121-4","article-title":"Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations","volume":"105","author":"Hausenloy","year":"2010","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0360","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.cardiores.2003.09.024","article-title":"New directions for protecting the heart against ischaemia\u2013reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway","volume":"61","author":"Hausenloy","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0365","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1365-2125.2007.03031.x","article-title":"The effect of age, gender, and body mass index on the pharmacokinetics and pharmacodynamics of vildagliptin in healthy volunteers","volume":"65","author":"He","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0370","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1463-1326.2009.01046.x","article-title":"Pharmacokinetics, pharmacodynamics and tolerability of multiple oral doses of linagliptin, a dipeptidyl peptidase-4 inhibitor in male type 2 diabetes patients","volume":"11","author":"Heise","year":"2009","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0375","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0008-6363(00)00229-7","article-title":"Vasoactive intestinal peptide: cardiovascular effects","volume":"49","author":"Henning","year":"2001","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0380","doi-asserted-by":"crossref","first-page":"19532","DOI":"10.1074\/jbc.M004586200","article-title":"Comodulation of CXCR4 and CD26 in human lymphocytes","volume":"276","author":"Herrera","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0385","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1161\/01.CIR.0000128213.96779.61","volume":"109","author":"Hiasa","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0390","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.jtcvs.2010.08.012","article-title":"Spliced stromal cell-derived factor-1alpha analog stimulates endothelial progenitor cell migration and improves cardiac function in a dose-dependent manner after myocardial infarction","volume":"140","author":"Hiesinger","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0395","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/jnen\/63.1.84","article-title":"SDF-1 (CXCL12) is upregulated in the ischemic penumbra following stroke: association with bone marrow cell homing to injury","volume":"63","author":"Hill","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0400","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1681\/ASN.2006090998","article-title":"Inhibition of hypoxia inducible factor hydroxylases protects against renal ischemia\u2013reperfusion injury","volume":"19","author":"Hill","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2011.12.007","article-title":"The novel DPP-4 inhibitors linagliptin and BI 14361 reduce infarct size after myocardial ischemia\/reperfusion in rats","author":"Hocher","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0410","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1164\/ajrccm.163.7.9911060","article-title":"Maintenance of cAMP in non-heart-beating donor lungs reduces ischemia\u2013reperfusion injury","volume":"163","author":"Hoffmann","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0415","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1161\/CIRCULATIONAHA.106.672451","article-title":"Stromal cell derived factor-1 alpha confers protection against myocardial ischemia\/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis","volume":"116","author":"Hu","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0420","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/cvr\/cvr014","article-title":"Parathyroid hormone is a DPP-IV inhibitor and increases SDF-1-driven homing of CXCR4(+) stem cells into the ischaemic heart","volume":"90","author":"Huber","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0425","first-page":"77","article-title":"Signalling pathways activated by glucagon-like peptide-1 (7\u201336) amide in the rat heart and their role in protection against ischaemia","volume":"19","author":"Huisamen","year":"2008","journal-title":"Cardiovasc J Afr"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0430","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10557-010-6271-7","article-title":"Pre-treatment with a DPP-4 inhibitor is infarct sparing in hearts from obese, pre-diabetic rats","volume":"25","author":"Huisamen","year":"2011","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0435","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1172\/JCI12150","article-title":"Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells","volume":"107","author":"Jackson","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0440","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.transproceed.2011.01.191","article-title":"Inhibition of Toll-like receptor 4 with vasoactive intestinal peptide attenuates liver ischemia\u2013reperfusion injury","volume":"43","author":"Jiang","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0445","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nm1400","article-title":"Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes","volume":"12","author":"Jin","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0455","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1093\/ejcts\/ezr180","article-title":"CD26\/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia\u2013reperfusion injury in mouse lung transplantation","volume":"41","author":"Jungraithmayr","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0460","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.peptides.2009.12.012","article-title":"Inhibition of CD26\/DPP IV attenuates ischemia\/reperfusion injury in orthotopic mouse lung transplants: the pivotal role of vasoactive intestinal peptide","volume":"31","author":"Jungraithmayr","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0465","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1475-097X.1990.tb00252.x","article-title":"Neuropeptide Y is released together with noradrenaline from the human heart during exercise and hypoxia","volume":"10","author":"Kaijser","year":"1990","journal-title":"Clin Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0470","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1172\/JCI17856","article-title":"Bone marrow stem cells contribute to repair of the ischemically injured renal tubule","volume":"112","author":"Kale","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0475","first-page":"952","article-title":"Protective role of intracoronary vasoactive intestinal peptide in ischemic and reperfused myocardium","volume":"268","author":"Kalfin","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0480","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/hc3501.093817","article-title":"Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines","volume":"104","author":"Kamihata","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0485","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1161\/CIRCHEARTFAILURE.110.960302","article-title":"Stromal cell-derived factor-1 retention and cardioprotection for ischemic myocardium","volume":"4","author":"Kanki","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0490","doi-asserted-by":"crossref","first-page":"e1369","DOI":"10.1136\/bmj.e1369","article-title":"Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis","volume":"344","author":"Karagiannis","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0495","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0196-9781(03)00108-6","article-title":"Glucagon-like peptide-1 (7\u201336) amide prevents the accumulation of pyruvate and lactate in the ischemic and non-ischemic porcine myocardium","volume":"24","author":"Kavianipour","year":"2003","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0500","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/01.CIR.0000046450.89986.50","article-title":"Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia","volume":"107","author":"Kawamoto","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0505","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1042\/bst0040347","article-title":"Dipeptidyl peptidase IV, a kidney microvillus serine proteinase: evidence for its large subunit molecular weight and endopeptidase activity","volume":"4","author":"Kenny","year":"1976","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0510","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.jss.2010.06.041","article-title":"Brain natriuretic peptide is not reno-protective during renal ischemia\u2013reperfusion injury in the rat","volume":"164","author":"Kim","year":"2010","journal-title":"J Surg Res"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0515","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/0-306-47920-6_26","article-title":"Dual role of dipeptidyl peptidase IV (DPP IV) in angiogenesis and vascular remodeling","volume":"524","author":"Kitlinska","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0520","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/86498","article-title":"Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function","volume":"7","author":"Kocher","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0525","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jss.2010.10.011","article-title":"Human atrial natriuretic peptide attenuates renal ischemia\u2013reperfusion injury","volume":"173","author":"Koga","year":"2012","journal-title":"J Surg Res"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0530","first-page":"1","article-title":"Loss of DPP4 activity is related to a prothrombogenic status of endothelial cells: implications for the coronary microvasculature of myocardial infarction patients","volume":"107","author":"Krijnen","year":"2011","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0535","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2261-9-31","article-title":"Lack of cardioprotection from subcutaneously and preischemic administered liraglutide in a closed chest porcine ischemia reperfusion model","volume":"9","author":"Kristensen","year":"2009","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0540","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00210-011-0665-3","article-title":"DPP4 deficiency preserves cardiac function via GLP-1 signaling in rats subjected to myocardial ischemia\/reperfusion","volume":"384","author":"Ku","year":"2011","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0545","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.peptides.2006.08.035","article-title":"Stress, NPY and vascular remodeling: implications for stress-related diseases","volume":"28","author":"Kuo","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0550","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1210\/en.2010-1098","article-title":"Differential effects of PPAR-{gamma} activation versus chemical or genetic reduction of DPP-4 activity on bone quality in mice","volume":"152","author":"Kyle","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0555","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0014-5793(01)02982-9","article-title":"Kinetic study of the processing by dipeptidyl-peptidase IV\/CD26 of neuropeptides involved in pancreatic insulin secretion","volume":"507","author":"Lambeir","year":"2001","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0560","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/713609354","article-title":"Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV","volume":"40","author":"Lambeir","year":"2003","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0565","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.bcp.2008.07.029","article-title":"DPP4 inhibitors for diabetes\u2014what next?","volume":"76","author":"Lambeir","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0570","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1172\/JCI16929","article-title":"Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles","volume":"111","author":"Lee","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0575","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000066761","article-title":"Vasoactive intestinal polypeptide and gastrin-releasing peptide attenuate hepatic microvasculatory disturbances following intestinal ischemia and reperfusion","volume":"66","author":"Leister","year":"2002","journal-title":"Digestion"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0580","doi-asserted-by":"crossref","first-page":"L285","DOI":"10.1152\/ajplung.00222.2007","article-title":"Retention of human bone marrow-derived cells in murine lungs following bleomycin-induced lung injury","volume":"295","author":"Liebler","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0585","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1097\/01.ASN.0000061595.28546.A0","article-title":"Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischemia\u2013reperfusion injury in mice","volume":"14","author":"Lin","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0590","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0167-0115(92)90084-8","article-title":"Vasoactive intestinal polypeptide (VIP) inhibits rat alveolar macrophage phagocytosis and chemotaxis in vitro","volume":"40","author":"Litwin","year":"1992","journal-title":"Regul Pept"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0595","doi-asserted-by":"crossref","first-page":"e34608","DOI":"10.1371\/journal.pone.0034608","article-title":"The role of SDF-1-CXCR4\/CXCR7 axis in the therapeutic effects of hypoxia-preconditioned mesenchymal stem cells for renal ischemia\/reperfusion injury","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0600","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1093\/eurheartj\/ehr309","article-title":"Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction","volume":"33","author":"Lonborg","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0605","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.1073\/pnas.80.18.5485","article-title":"Mammalian pancreatic preproglucagon contains three glucagon-related peptides","volume":"80","author":"Lopez","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0610","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0002-8703(96)90408-1","article-title":"Early increase of vasoactive intestinal peptide in acute myocardial infarction","volume":"132","author":"Lucia","year":"1996","journal-title":"Am Heart J"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0615","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0002-9149(97)89323-X","article-title":"Effect of age and relation to mortality on serial changes of vasoactive intestinal peptide in acute myocardial infarction","volume":"77","author":"Lucia","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0620","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00395-005-0521-z","article-title":"Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction","volume":"100","author":"Ma","year":"2005","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0625","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/nm912","article-title":"Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts","volume":"9","author":"Mangi","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0630","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1515\/bc.2011.002","article-title":"Expression and spatial heterogeneity of dipeptidyl peptidases in endothelial cells of conduct vessels and capillaries","volume":"392","author":"Matheeussen","year":"2011","journal-title":"Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0635","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jss.2009.03.016","article-title":"Single dose GLP-1-Tf ameliorates myocardial ischemia\/reperfusion injury","volume":"165","author":"Matsubara","year":"2011","journal-title":"J Surg Res"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0640","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jacc.2011.07.053","article-title":"A dipeptidyl peptidase-4 inhibitor, des-fluoro-sitagliptin, improves endothelial function and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice","volume":"59","author":"Matsubara","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0645","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1084\/jem.20071903","article-title":"Essential but differential role for CXCR4 and CXCR7 in the therapeutic homing of human renal progenitor cells","volume":"205","author":"Mazzinghi","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0650","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0167-0115(93)90435-B","article-title":"Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV","volume":"49","author":"Mentlein","year":"1993","journal-title":"Regul Pept"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0655","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1432-1033.1993.tb17986.x","article-title":"Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7\u201336)amide, peptide histidine methionine and is responsible for their degradation in human serum","volume":"214","author":"Mentlein","year":"1993","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0660","doi-asserted-by":"crossref","first-page":"15371","DOI":"10.1016\/S0021-9258(18)55404-1","article-title":"Vasoactive intestinal peptide, a singlet oxygen quencher","volume":"265","author":"Misra","year":"1990","journal-title":"J Biol Chem"},{"issue":"Suppl. 3","key":"10.1016\/j.pharmthera.2012.07.012_bb0665","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1185\/03007995.2011.602964","article-title":"Safety of dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized clinical trials","volume":"27","author":"Monami","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2011.10.090","article-title":"Mononuclear cell adenosine deaminase and CD26\/dipeptidylpeptidase-IV activities are sensitive markers of reperfusion during percutaneous transluminal angioplasty","author":"Moro","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0675","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1096\/fj.05-4770fje","article-title":"Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors","volume":"20","author":"Movafagh","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0680","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nature02446","article-title":"Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts","volume":"428","author":"Murry","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0685","first-page":"617","article-title":"Vasoactive intestinal peptide ameliorates reperfusion injury in rat lung transplantation","volume":"17","author":"Nagahiro","year":"1998","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0690","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1182\/blood-2005-04-1492","article-title":"Skin homing of Sezary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26\/dipeptidylpeptidase IV","volume":"107","author":"Narducci","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0695","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/jcb.21043","article-title":"Cytokines and hematopoietic stem cell mobilization","volume":"99","author":"Nervi","year":"2006","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0700","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1124\/jpet.104.073890","article-title":"Glucagon-like peptide-1 limits myocardial stunning following brief coronary occlusion and reperfusion in conscious canines","volume":"312","author":"Nikolaidis","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0705","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1161\/01.CIR.0000120505.91348.58","article-title":"Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion","volume":"109","author":"Nikolaidis","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0710","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2337\/db08-1193","article-title":"GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice","volume":"58","author":"Noyan-Ashraf","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0715","doi-asserted-by":"crossref","first-page":"E1209","DOI":"10.1152\/ajpendo.00237.2004","article-title":"Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease","volume":"287","author":"Nystrom","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0720","doi-asserted-by":"crossref","first-page":"F326","DOI":"10.1152\/ajprenal.00480.2007","article-title":"Inhibition of tubular cell proliferation by neutralizing endogenous HGF leads to renal hypoxia and bone marrow-derived cell engraftment in acute renal failure","volume":"294","author":"Ohnishi","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0725","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00210-007-0232-0","article-title":"Structure\u2013activity relationship of vasoactive intestinal peptide (VIP): potent agonists and potential clinical applications","volume":"377","author":"Onoue","year":"2008","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0730","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/35070587","article-title":"Bone marrow cells regenerate infarcted myocardium","volume":"410","author":"Orlic","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0735","doi-asserted-by":"crossref","first-page":"10344","DOI":"10.1073\/pnas.181177898","article-title":"Mobilized bone marrow cells repair the infarcted heart, improving function and survival","volume":"98","author":"Orlic","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0740","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.phrs.2009.06.004","article-title":"The cardioprotective and inotropic components of the postconditioning effects of GLP-1 and GLP-1(9\u201336)a in an isolated rat heart","volume":"60","author":"Ossum","year":"2009","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0745","first-page":"L369","article-title":"Paraquat-induced lung injury\u2014prevention by vasoactive-intestinal-peptide and related peptide helodermin","volume":"265","author":"Pakbaz","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0750","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/ni813","article-title":"G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4","volume":"3","author":"Petit","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0755","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1023\/A:1012808525370","article-title":"Cloning and relative expression analysis of rat stromal cell derived factor-1 (SDF-1)1: SDF-1 alpha mRNA is selectively induced in rat model of myocardial infarction","volume":"25","author":"Pillarisetti","year":"2001","journal-title":"Inflammation"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0760","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/cvr\/cvp313","article-title":"Impaired recruitment of HHT-1 mononuclear cells to the ischaemic heart is due to an altered CXCR4\/CD26 balance","volume":"85","author":"Post","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0765","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/75022","article-title":"Active movement of T cells away from a chemokine","volume":"6","author":"Poznansky","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0770","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCIMAGING.109.899377","article-title":"DPP-4 inhibition by sitagliptin improves the myocardial response to dobutamine stress and mitigates stunning in a pilot study of patients with coronary artery disease","volume":"3","author":"Read","year":"2010","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0775","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cca.2006.08.027","article-title":"Brain natriuretic peptide limits myocardial infarct size dependent of nitric oxide synthase in rats","volume":"377","author":"Ren","year":"2007","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0780","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1016\/j.transproceed.2010.09.163","article-title":"B-type natriuretic peptide pretreatment attenuates heart ischemia\u2013reperfusion injury in rats","volume":"42","author":"Ren","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0785","first-page":"L374","article-title":"GLP-1 stimulates secretion of macromolecules from airways and relaxes pulmonary artery","volume":"265","author":"Richter","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0790","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.yjmcc.2010.08.022","article-title":"Effects of neuropeptide Y on collateral development in a swine model of chronic myocardial ischemia","volume":"49","author":"Robich","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0795","first-page":"1223","article-title":"The chemokine SDF-1\/CXCL12 contributes to the \u2018homing\u2019 of umbilical cord blood cells to a hypoxic\u2013ischemic lesion in the rat brain","volume":"88","author":"Rosenkranz","year":"2010","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0800","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000040880","article-title":"Peripheral CD34+ progenitor cells express CD26 and contain increased dipeptidyl peptidase IV activity","volume":"100","author":"Ruiz","year":"1998","journal-title":"Acta Haematol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0805","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.jacc.2004.07.057","article-title":"Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia","volume":"44","author":"Sabatine","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0810","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1126\/science.169.3951.1217","article-title":"Polypeptide with broad biological activity: isolation from small intestine","volume":"169","author":"Said","year":"1970","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0815","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.2337\/db09-0955","article-title":"Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice","volume":"59","author":"Sauv\u00e9","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0820","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.npep.2006.07.004","article-title":"Mechanisms of vasoactive intestinal peptide-elicited coronary vasodilation in the isolated perfused rat heart","volume":"40","author":"Sawmiller","year":"2006","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0825","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.npep.2004.05.008","article-title":"Coronary vascular effects of vasoactive intestinal peptide in the isolated perfused rat heart","volume":"38","author":"Sawmiller","year":"2004","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0830","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1161\/CIRCULATIONAHA.107.694992","article-title":"Stromal cell-derived factor-1alpha is cardioprotective after myocardial infarction","volume":"117","author":"Saxena","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0835","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1369\/jhc.7A7319.2007","article-title":"Regulation of expression and function of dipeptidyl peptidase 4 (DP4), DP8\/9, and DP10 in allergic responses of the lung in rats","volume":"56","author":"Schade","year":"2008","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0840","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00125-011-2368-1","article-title":"Diabetes: impaired damage control","volume":"55","author":"Schaper","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0845","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1084\/jem.20030267","article-title":"Regulation of the chemokine receptor CXCR4 by hypoxia","volume":"198","author":"Schioppa","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0850","doi-asserted-by":"crossref","DOI":"10.1111\/j.1582-4934.2012.01539.x","article-title":"Myocardial regeneration by transplantation of modified endothelial progenitor cells expressing SDF-1 in a rat model","author":"Schuh","year":"2012","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0855","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.exphem.2011.10.010","article-title":"Dipeptidyl peptidase IV (DPPIV\/CD26) inhibition does not improve engraftment of unfractionated syngeneic or allogeneic bone marrow after non-myeloablative conditioning","volume":"40","author":"Schwaiger","year":"2012","journal-title":"Exp Hematol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0860","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1161\/CIRCULATIONAHA.107.718718","article-title":"Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction","volume":"116","author":"Segers","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0865","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1161\/CIRCULATIONAHA.111.041418","article-title":"Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis","volume":"124","author":"Shah","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0870","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1006\/geno.1995.1180","article-title":"Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene","volume":"28","author":"Shirozu","year":"1995","journal-title":"Genomics"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0875","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jacc.2008.10.008","volume":"53","author":"Skyler","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0880","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.regpep.2007.10.001","article-title":"Protective effects of GLP-1 analogues exendin-4 and GLP-1(9\u201336) amide against ischemia\u2013reperfusion injury in rat heart","volume":"146","author":"Sonne","year":"2008","journal-title":"Regul Pept"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0885","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1093\/ndt\/gfq311","article-title":"SDF-1 provides morphological and functional protection against renal ischaemia\/reperfusion injury","volume":"25","author":"Stokman","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0890","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1093\/ndt\/gfp050","article-title":"Haematopoietic stem cell migration to the ischemic damaged kidney is not altered by manipulating the SDF-1\/CXCR4-axis","volume":"24","author":"Stroo","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0895","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.biopha.2009.09.024","article-title":"B-type natriuretic peptide protects cardiomyocytes at reperfusion via mitochondrial calcium uniporter","volume":"64","author":"Sun","year":"2010","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0900","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1248\/bpb.32.1545","article-title":"B-type natriuretic peptide-induced cardioprotection against reperfusion is associated with attenuation of mitochondrial permeability transition","volume":"32","author":"Sun","year":"2009","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0905","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/FJC.0b013e31821e5626","article-title":"DPP-4 (CD26) inhibitor alogliptin inhibits atherosclerosis in diabetic apolipoprotein E-deficient mice","volume":"58","author":"Ta","year":"2011","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0910","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1253\/circj.CJ-09-1021","article-title":"Role of the SDF-1\/CXCR4 system in myocardial infarction","volume":"74","author":"Takahashi","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.regpep.2004.10.014","article-title":"Mobilizing of haematopoietic stem cells to ischemic myocardium by plasmid mediated stromal-cell-derived factor-1alpha (SDF-1alpha) treatment","volume":"125","author":"Tang","year":"2005","journal-title":"Regul Pept"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0920","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.ejcts.2009.04.052","article-title":"Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats","volume":"36","author":"Tang","year":"2009","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0925","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.metabol.2011.11.011","article-title":"Effects of PKF275-055, a dipeptidyl peptidase-4 inhibitor, on the development of atherosclerotic lesions in apolipoprotein E-null mice","volume":"61","author":"Terasaki","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0930","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ijcard.2009.09.555","article-title":"Safety and efficacy of SITAgliptin plus GRanulocyte-colony-stimulating factor in patients suffering from Acute Myocardial Infarction (SITAGRAMI-Trial)\u2014rationale, design and first interim analysis","volume":"145","author":"Theiss","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0935","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.scr.2011.05.003","article-title":"Dual stem cell therapy after myocardial infarction acts specifically by enhanced homing via the SDF-1\/CXCR4 axis","volume":"7","author":"Theiss","year":"2011","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0940","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jacc.2008.10.033","article-title":"Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury","volume":"53","author":"Timmers","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0945","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1111\/j.1523-1755.2005.00275.x","article-title":"Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury","volume":"67","author":"T\u00f6gel","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0950","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/hc0102.101442","article-title":"Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart","volume":"105","author":"Toma","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0955","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1365-2125.2011.03937.x","article-title":"Effect of rifampicin on the pharmacokinetics and pharmacodynamics of saxagliptin, a dipeptidyl peptidase-4 inhibitor, in healthy subjects","volume":"72","author":"Upreti","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0960","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1210\/er.2011-1052","article-title":"Cardiovascular biology of the incretin system","volume":"33","author":"Ussher","year":"2012","journal-title":"Endocr Rev"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0965","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4103\/1319-3767.65187","article-title":"Exaggerated liver injury induced by renal ischemia reperfusion in diabetes: effect of exenatide","volume":"16","author":"Vaghasiya","year":"2010","journal-title":"Saudi J Gastroenterol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0970","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.regpep.2010.08.007","article-title":"Sitagliptin protects renal ischemia reperfusion induced renal damage in diabetes","volume":"166","author":"Vaghasiya","year":"2011","journal-title":"Regul Pept"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0975","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3181\/00379727-195-43117","article-title":"Opposite effects of diabetes on nephrotoxic and ischemic acute tubular necrosis","volume":"195","author":"Wald","year":"1990","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0980","doi-asserted-by":"crossref","first-page":"R811","DOI":"10.1152\/ajpregu.00543.2007","article-title":"Cyclosporine increases ischemia-induced endothelial progenitor cell mobilization through manipulation of the CD26 system","volume":"294","author":"Wang","year":"2008","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0985","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.brainres.2007.11.068","article-title":"SDF-1alpha\/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model","volume":"1195","author":"Wang","year":"2008","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0990","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.yjmcc.2006.03.006","article-title":"Enalapril increases ischemia-induced endothelial progenitor cell mobilization through manipulation of the CD26 system","volume":"41","author":"Wang","year":"2006","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb0995","doi-asserted-by":"crossref","first-page":"H275","DOI":"10.1152\/ajpheart.00765.2009","article-title":"Combining neuropeptide Y and mesenchymal stem cells reverses remodeling after myocardial infarction","volume":"298","author":"Wang","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb1000","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/ejcts\/ezr246","article-title":"Lung transplantation research: impact of a new surgical model","volume":"41","author":"Warnecke","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb1005","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0014-5793(94)01430-9","article-title":"Tissue-specific expression of the human receptor for glucagon-like peptide-I: brain, heart and pancreatic forms have the same deduced amino acid sequences","volume":"358","author":"Wei","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb1010","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1046\/j.1365-201X.1996.42256000.x","article-title":"Distribution of GLP-1 and PACAP receptors in human tissues","volume":"157","author":"Wei","year":"1996","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb1015","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1620\/tjem.219.107","article-title":"Pretreatment with B-type natriuretic peptide protects the heart from ischemia\u2013reperfusion injury by inhibiting myocardial apoptosis","volume":"219","author":"Wu","year":"2009","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb1020","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1097\/00029330-200811010-00005","article-title":"Effects and mechanism of glucagon-like peptide-1 on injury of rats cardiomyocytes induced by hypoxia\u2013reoxygenation","volume":"121","author":"Xie","year":"2008","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb1025","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1161\/01.CIR.0000055313.77510.22","article-title":"Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization","volume":"107","author":"Yamaguchi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb1030","doi-asserted-by":"crossref","first-page":"H1454","DOI":"10.1152\/ajpheart.00867.2009","article-title":"The myocardial infarct size-limiting effect of sitagliptin is PKA-dependent, whereas the protective effect of pioglitazone is partially dependent on PKA","volume":"298","author":"Ye","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb1035","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00395-011-0216-6","article-title":"The potential effects of anti-diabetic medications on myocardial ischemia\u2013reperfusion injury","volume":"106","author":"Ye","year":"2011","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb1040","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1475-2840-10-85","article-title":"Early and late effects of the DPP-4 inhibitor vildagliptin in a rat model of post-myocardial infarction heart failure","volume":"10","author":"Yin","year":"2011","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb1045","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.stem.2009.02.013","article-title":"Synergy between CD26\/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction","volume":"4","author":"Zaruba","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb1050","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1016\/j.transproceed.2006.10.048","article-title":"Ischemia\/reperfusion injury: the role of CD26\/dipeptidyl-peptidase-IV-inhibition in lung transplantation","volume":"38","author":"Zhai","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb1055","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.healun.2006.11.601","article-title":"Intragraft DPP IV inhibition attenuates post-transplant pulmonary ischemia\/reperfusion injury after extended ischemia","volume":"26","author":"Zhai","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb1060","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/TP.0b013e31819e04c3","article-title":"Primary graft dysfunction in lung transplantation: the role of CD26\/dipeptidylpeptidase IV and vasoactive intestinal peptide","volume":"87","author":"Zhai","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb1065","doi-asserted-by":"crossref","first-page":"H1339","DOI":"10.1152\/ajpheart.00592.2010","article-title":"Genetically manipulated progenitor cell sheet with diprotin A improves myocardial function and repair of infarcted hearts","volume":"299","author":"Zhang","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb1070","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1089\/ten.2006.0013","article-title":"Controlled release of stromal cell-derived factor-1 alpha in situ increases c-kit+ cell homing to the infarcted heart","volume":"13","author":"Zhang","year":"2007","journal-title":"Tissue Eng"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb1075","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1124\/jpet.106.100982","article-title":"Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts","volume":"317","author":"Zhao","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb1080","doi-asserted-by":"crossref","first-page":"H976","DOI":"10.1152\/ajpheart.01134.2008","article-title":"Stem cell homing and angiomyogenesis in transplanted hearts are enhanced by combined intramyocardial SDF-1alpha delivery and endogenous cytokine signaling","volume":"296","author":"Zhao","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb1085","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/31269","article-title":"Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development","volume":"393","author":"Zou","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2012.07.012_bb1090","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1050-1738(02)00232-3","article-title":"Neuropeptide Y: a novel mechanism for ischemic angiogenesis","volume":"13","author":"Zukowska","year":"2003","journal-title":"Trends Cardiovasc Med"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725812001611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725812001611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T15:36:20Z","timestamp":1643038580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725812001611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":217,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0163725812001611"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2012.07.012","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}